Delivery Order SPE2DB24D2003-SPE2DB25FXND5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ZENPEP (pancreatic enzyme replacement therapy) in 40,000-unit capsule form packaged in 100-count bottles. This $8,016.98 firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through competitive...
- The Defense Logistics Agency awarded a delivery order valued at $5,778.20 to AmerisourceBergen Drug Corp for ZENPEP DR 40,000 Unit Capsule 100s on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside provisions, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a delivery order valued at $31,256.47 to AmerisourceBergen Drug Corp for 100,000 units of Zenpep DR 40,000 unit capsules, with completion targeted for September 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value and extends through...
- This is a $9,017.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,548 units of the drug ZENPEP DR 40,000 UNIT CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award is a delivery order valued at $11,787.39 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a medical product, with a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,034.97, is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S to support federal healthcare programs. The contract has a period of performance through May 14, 2024 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999...
- This federal contract award, valued at $27,032.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price contract. No set-aside designation was used for this award. AmerisourceBergen holds a...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,364.06, is a delivery order for the supply of 40,000 units of the drug ZENPEP in 100-count capsule bottles. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,127.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,564,242,620 ZENPEP DR 15,000 UNIT CAPSULES 100S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a prominent pharmaceutical distribution company, for the supply of 40,000-unit capsules of the drug Zenpep. The award has a ceiling value of $6,846.77 and a completion date of September 10, 2024. The contract is a firm-fixed-price delivery order, which means the price is set and not subject to adjustment. AmerisourceBergen, through its Corporate Office division, has been awarded this...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXND5Delivery Order
AmerisourceBergen Drug Corp was awarded a $7,684.70 delivery order contract by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Zenpep DR 60,000 Unit Capsules in quantities of 100 units. The contract, issued under firm fixed pricing with no set-aside designation, has an ultimate completion date of September 26, 2025. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order for Zenpep, a pancreatic enzyme replacement medication used to treat pancreatic insufficiency, exemplifies the company's extensive portfolio of pharmaceutical products distributed across the federal healthcare supply chain. As a competitively awarded contract with firm fixed pricing, this procurement demonstrates the contractor's continued capability to meet DLA's pharmaceutical supply requirements for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/25/25 |